Bruker Posts 35 Percent Q3 Revenue Growth, Misses EPS Estimate | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported a 35 percent increase in third-quarter revenues but fell short of analyst EPS estimates by a penny.

For the three months ended Sept. 30, the firm said it had $418.4 million in revenues, up from $310.2 million a year ago and ahead of Wall Street expectations of $393.2 million. Organically revenues were up 11 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.